193 related articles for article (PubMed ID: 37288658)
21. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
22. The Hypoxia-Adenosine Link during Myocardial Ischemia-Reperfusion Injury.
Ruan W; Ma X; Bang IH; Liang Y; Muehlschlegel JD; Tsai KL; Mills TW; Yuan X; Eltzschig HK
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009485
[TBL] [Abstract][Full Text] [Related]
23. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
24. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
[TBL] [Abstract][Full Text] [Related]
25. Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice.
Wu KC; Lee CY; Chou FY; Chern Y; Lin CJ
Brain Behav Immun; 2020 Feb; 84():59-71. PubMed ID: 31751618
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
27. Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.
Miller SR; Lane TR; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Drug Metab Dispos; 2021 Jul; 49(7):479-489. PubMed ID: 33980604
[TBL] [Abstract][Full Text] [Related]
28. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
[TBL] [Abstract][Full Text] [Related]
29. Myocardial protection in beating heart cardiac surgery: I: pre- or postconditioning with inhibition of es-ENT1 nucleoside transporter and adenosine deaminase attenuates post-MI reperfusion-mediated ventricular fibrillation and regional contractile dysfunction.
Abd-Elfattah AS; Aly H; Hanan S; Wechsler AS
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):250-5. PubMed ID: 22329983
[TBL] [Abstract][Full Text] [Related]
30. Contribution of ENT4 to adenosine uptake in AC16 human cardiomyocytes under simulated ischemic conditions and its potential role in cardioprotection.
Wong ES; Li R; Li J; Zheng C; Shiu PH; Rangsinth P; Seto SW; Leung GP
Mol Biol Rep; 2022 Nov; 49(11):11201-11208. PubMed ID: 36107375
[TBL] [Abstract][Full Text] [Related]
31. Tubuloglomerular feedback and renal function in mice with targeted deletion of the type 1 equilibrative nucleoside transporter.
Li L; Mizel D; Huang Y; Eisner C; Hoerl M; Thiel M; Schnermann J
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F382-9. PubMed ID: 23269643
[TBL] [Abstract][Full Text] [Related]
32. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
Leung GP; Man RY; Tse CM
Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
[TBL] [Abstract][Full Text] [Related]
33. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
Playa H; Lewis TA; Ting A; Suh BC; Muñoz B; Matuza R; Passer BJ; Schreiber SL; Buolamwini JK
Bioorg Med Chem Lett; 2014 Dec; 24(24):5801-5804. PubMed ID: 25454272
[TBL] [Abstract][Full Text] [Related]
34. Attenuating myocardial ischemia by targeting A2B adenosine receptors.
Eltzschig HK; Bonney SK; Eckle T
Trends Mol Med; 2013 Jun; 19(6):345-54. PubMed ID: 23540714
[TBL] [Abstract][Full Text] [Related]
35. Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.
Naydenova Z; Rose JB; Coe IR
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2687-92. PubMed ID: 18424636
[TBL] [Abstract][Full Text] [Related]
36. Myeloid hypoxia-inducible factor HIF1A provides cardio-protection during ischemia and reperfusion
Heck-Swain KL; Li J; Ruan W; Yuan X; Wang Y; Koeppen M; Eltzschig HK
Front Cardiovasc Med; 2022; 9():970415. PubMed ID: 36247475
[TBL] [Abstract][Full Text] [Related]
37. The Critical Role of Equilibrative Nucleoside Transporter-2 in Modulating Cerebral Damage and Vascular Dysfunction in Mice with Brain Ischemia-Reperfusion.
Chiang HL; Wu KC; Chen YY; Ho CJ; Wang HL; Fu YH; Chen WY; Lin CJ
Pharm Res; 2023 Nov; 40(11):2541-2554. PubMed ID: 37498500
[TBL] [Abstract][Full Text] [Related]
38. The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity.
Ramadan A; Naydenova Z; Stevanovic K; Rose JB; Coe IR
Purinergic Signal; 2014; 10(2):305-12. PubMed ID: 24163005
[TBL] [Abstract][Full Text] [Related]
39. Cardioprotective role of APIP in myocardial infarction through ADORA2B.
Lim B; Jung K; Gwon Y; Oh JG; Roh JI; Hong SH; Kho C; Park WJ; Lee HW; Bae JW; Jung YK
Cell Death Dis; 2019 Jul; 10(7):511. PubMed ID: 31263105
[TBL] [Abstract][Full Text] [Related]
40. Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions.
Zhang D; Xiong W; Albensi BC; Parkinson FE
J Neurochem; 2011 Jul; 118(1):4-11. PubMed ID: 21395582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
